Novel new diabetes treatment fares well in clinical trials
Clinical trials on a novel new type 2 diabetes treatment lowered glucose, did not increase lipids, and was well tolerated in patients with the chronic disease.
Lipitor side effects lawsuits mount against Pfizer
Lawsuits are mounting against Pfizer Inc., alleging the company withheld information that its cholesterol-lowering statin drug Lipitor could cause women to develop type 2 diabetes. In the past five months, Lipitor side effects lawsuits have jumped from 56 to more than
Newborn head and body support products recalled due to presence of mold
Children’s Medical Ventures is recalling its Gel-E Donut and Squishon 2 products used in hospitals to support and cradle an infant’s head or body because of numerous complaints about visible mold on the outer surface of the products. The mold
Mirena IUD linked to increased breast cancer risk in premenopausal women
Premenopausal women who use a hormone-releasing intrauterine device, such as the Mirena IUD, are at greater risk of developing breast cancer, according to a study recently published in the journal Obstetrics & Gynecology.
Insulin therapy may help prevent acute pancreatitis
Acute pancreatitis affects about 20,000 people every year and results in 1,000 deaths. It can also increase the risk for pancreatic cancer, one of the most deadly forms of the disease. Yet, there is no immediate cure for the painful and
New testosterone replacement capsule fares well in clinical trials
Clinical trials for Clarus Therapeutic’s new testosterone replacement treatment Rextoro show the drug is comparable to other testosterone therapies and, if approved by the Food and Drug Administration (FDA), could provide patients with yet another treatment option to boost the
Bone marrow treatment restores hair growth in patients with alopecia
Clinical trials on FDA-approved drugs for other conditions have been shown to restore hair growth in some patients with alopecia areata, an autoimmune disease that causes hair loss.
Drug company tests new drug to boost testosterone levels in men
A new treatment designed to boost testosterone levels in men, which is not a testosterone replacement therapy, is currently being tested in clinical trials. If data is favorable, the drug could be considered for regulatory approval by the end of
Second transvaginal mesh lawsuit against Boston Scientific goes to trial
The second bellwether trial involving injuries from Boston Scientific’s transvaginal mesh device is underway in Massachusetts state court, and plaintiffs are hoping for a different outcome than the first.
Testosterone levels tend to fluctuate significantly in younger men but remain more constant in older men
Most schools of thought suggest that measuring testosterone levels in men can be tricky because the hormone levels vary from day to day as well as hour to hour. However, a new study finds that only young men experience statistically